Clinical Trial: Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikungunya Vaccines Compared to Separate Administration in Adults Aged 18 to 59 Years.

U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT06973772) titled 'Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikungunya Vaccines Compared to Separate Administration in Adults Aged 18 to 59 Years.' on April 28.

Brief Summary: This randomized, controlled, double blind trial aims at assessing the safety and immunogenicity profiles of the co-administered Live Attenuated Dengue and Chikungunya vaccines comparatively to the isolated administration, in the adult population aged 18 to 59 years without prior exposure to either arbovirus.

Study Start Date: Aug., 2025

Study Type: INTERVENTIONAL

Condition: Dengue Chikungunya

Intervention: BIOLO...